Cargando…

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

Anti-hepatitis C virus (HCV) cross-neutralizing human monoclonal antibodies, directed against conserved epitopes on surface E2 glycoprotein, are central tools for understanding virus-host interplay, and for planning strategies for prevention and treatment of this infection. Recently, we developed a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mancini, Nicasio, Diotti, Roberta A., Perotti, Mario, Sautto, Giuseppe, Clementi, Nicola, Nitti, Giovanni, Patel, Arvind H., Ball, Jonathan K., Clementi, Massimo, Burioni, Roberto
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785886/ https://www.ncbi.nlm.nih.gov/pubmed/20011511 http://dx.doi.org/10.1371/journal.pone.0008254

Ejemplares similares

HCV Proteins and Immunoglobulin Variable Gene (IgV) Subfamilies in HCV-Induced Type II Mixed Cryoglobulinemia: A Concurrent Pathogenetic Role
por: Sautto, Giuseppe, et al.
Publicado: (2012)

Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)
por: Sautto, Giuseppe, et al.
Publicado: (2012)

Neutralization Interfering Antibodies: A “Novel” Example of Humoral Immune Dysfunction Facilitating Viral Escape?
por: Nicasio, Mancini, et al.
Publicado: (2012)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
por: Sautto, Giuseppe A, et al.
Publicado: (2016)

A Biologically-validated HCV E1E2 Heterodimer Structural Model
por: Castelli, Matteo, et al.
Publicado: (2017)

Possible Future Monoclonal Antibody (mAb)-Based Therapy against Arbovirus Infections
por: Sautto, Giuseppe, et al.
Publicado: (2013)

Anti-HIV-1 Response Elicited in Rabbits by Anti-Idiotype Monoclonal Antibodies Mimicking the CD4-Binding Site
por: Burioni, Roberto, et al.
Publicado: (2008)

Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
por: Sautto, Giuseppe, et al.
Publicado: (2013)

Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines
por: Clementi, Nicola, et al.
Publicado: (2012)

Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro
por: Clementi, Nicola, et al.
Publicado: (2020)

Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols
por: Caputo, Valeria, et al.
Publicado: (2020)

Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2
por: Criscuolo, Elena, et al.
Publicado: (2022)

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
por: Diotti, Roberta Antonia, et al.
Publicado: (2016)

Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens
por: Clementi, Nicola, et al.
Publicado: (2012)

JC Polyomavirus (JCV) and Monoclonal Antibodies: Friends or Potential Foes?
por: Diotti, Roberta Antonia, et al.
Publicado: (2013)

A closer look at prion strains: Characterization and important implications
por: Solforosi, Laura, et al.
Publicado: (2013)

Peptide-Based Vaccinology: Experimental and Computational Approaches to Target Hypervariable Viruses through the Fine Characterization of Protective Epitopes Recognized by Monoclonal Antibodies and the Identification of T-Cell-Activating Peptides
por: Castelli, Matteo, et al.
Publicado: (2013)

A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes
por: Clementi, Nicola, et al.
Publicado: (2011)

A Non-VH1-69 Heterosubtypic Neutralizing Human Monoclonal Antibody Protects Mice against H1N1 and H5N1 Viruses
por: De Marco, Donata, et al.
Publicado: (2012)

Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials
por: Criscuolo, Elena, et al.
Publicado: (2021)

Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy
por: Castelli, Matteo, et al.
Publicado: (2021)

Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies
por: Velázquez-Moctezuma, Rodrigo, et al.
Publicado: (2021)

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
por: Criscuolo, E., et al.
Publicado: (2019)

A Human Stem Cell-Derived Neurosensory–Epithelial Circuitry on a Chip to Model Herpes Simplex Virus Reactivation
por: Mazzara, Pietro Giuseppe, et al.
Publicado: (2022)

Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
por: Augestad, Elias H., et al.
Publicado: (2020)

SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital
por: Ferrari, Davide, et al.
Publicado: (2022)

Differential Composition of Vaginal Microbiome, but Not of Seminal Microbiome, Is Associated With Successful Intrauterine Insemination in Couples With Idiopathic Infertility: A Prospective Observational Study
por: Amato, Virginia, et al.
Publicado: (2019)

Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
por: Fan, Chengcheng, et al.
Publicado: (2022)

Viral Respiratory Pathogens and Lung Injury
por: Clementi, Nicola, et al.
Publicado: (2021)

Role of HVR1 sequence similarity in the cross-genotypic neutralization of HCV
por: Mosa, Alexander I., et al.
Publicado: (2020)

Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
por: Severa, Martina, et al.
Publicado: (2021)

Human Monoclonal Antibodies to a Novel Cluster of Conformational Epitopes on HCV E2 with Resistance to Neutralization Escape in a Genotype 2a Isolate
por: Keck, Zhen-yong, et al.
Publicado: (2012)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Dual-Domain Reporter Approach for Multiplex Identification of Major SARS-CoV-2 Variants of Concern in a Microarray-Based Assay
por: Damin, Francesco, et al.
Publicado: (2023)

Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
por: Kapingidza, A. Brenda, et al.
Publicado: (2023)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
por: Clementi, Nicola, et al.
Publicado: (2021)

Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
por: Yi, Guohua, et al.
Publicado: (2013)

Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes
por: GORI, MARIA, et al.
Publicado: (2022)

Correction: Chimeric Rhinoviruses Displaying MPER Epitopes Elicit Anti-HIV Neutralizing Responses
por: Yi, Guohua, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3qeq0t881b1hi8r55cm3q9il08